Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Letter]

Linxuan Wu,1,* Jian Hu,2,3,* Peng Yao2,3 1Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China; 2First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China; 3National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, People’s Republic of China*These authors contributed equally to this workCorrespondence: Peng Yao, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine/National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, 150006, People’s Republic of China, Email [email protected]